The FDA has a history of stepmotherly behaviour with Amarin (AMRN). We saw it between 2013 and 2015, when the FDA issued a CRL to Amarin when the company asked for a very reasonable label expansion - and the FDA took an entire year to even issue the CRL. The saga of those sordid years can be...

Shares of Aerie Pharmaceuticals (NASDAQ: AERI) jumped nearly 22% today after the company published an October investor presentation. The slide deck indicates that the ophthalmology, or eye-focused, pharma experienced a surge in the number of bottles of Rhopressa and Rocklatan shipped to phar...

Gainers: Synthesis Energy Systems (NASDAQ: SES ) +81% . MOGU (NYSE: MOGU ) +20% . Purple Innovation (NASDAQ: PRPL ) +19% . Fastenal (NASDAQ: FAST ) +17% . Aerie Pharmaceuticals (NASDAQ: AERI ) +17% . Valaris (NYSE: VAL ) +16% . Mmtec (NASDAQ: MTC ) +15% . Aclaris Therapeutics (NASD...